Breaking News, Promotions & Moves

Boehringer Ingelheim

Albert Ros has been appointed executive vice president of sales and marketing for Boehringer Ingelheim’s prescription medicines business. In his new role, Mr. Ros will lead the U.S. sales and marketing strategy of the company’s core brands.

“We are pleased to have Albert in such an important leadership role,” said J. Martin Carroll, president and chief executive officer, Boehringer Ingelheim. “Albert is a valuable member of the Boehringer Ingelheim team and he possesses an impressive range of global sales and marketing experience.”

Mr. Ros has been with the company for 14 years and previously served as head of the corporate division for marketing of prescription medicines. In this position, Mr. Ros led the development of four global products including Spiriva, Flomax, Mirapex and Micardis. Previously, he served as the country manager for Boehringer Ingelheim Brazil and the business unit head of Boehringer Ingelheim Spain.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters